Pre- versus post-dilution haemofiltration: a prospective randomised cross-over study

Completed

• Conditions: Acute renal failure; Urological and Genital Diseases; Renal failure

• Registration Number: ISRCTN38768865
• Lead Sponsor: Academic Medical Centre (Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-07-06
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

Eight critically ill patients with an indication for renal replacement therapy

Exclusion Criteria

Recent bleeding, treatment with aspirin within one week before inclusion or with therapeutic doses of unfractionated or low molecular weight heparin within 12 hours before inclusion or results of routine coagulation tests such as protrombin time (PT) and activated partial thromboplastin time (APTT) exceeding twice the upper limit of normal

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Extracorporeal circuit survival time

Secondary Outcome Measures

Name	Time	Method
Platelet activation, thrombin generation, urea clearance